Barrett Esophagus
A condition with damage to the lining of the lower ESOPHAGUS resulting from chronic acid reflux (ESOPHAGITIS, REFLUX). Through the process of metaplasia, the squamous cells are replaced by a columnar epithelium with cells resembling those of the INTESTINE or the salmon-pink mucosa of the STOMACH. Barrett's columnar epithelium is a marker for severe reflux and precursor to ADENOCARCINOMA of the esophagus.
Drugs by status
Approved for this indication (1)
Phase 4 trials (8)
Phase 3 trials (2)
Phase 2 trials (11)
Phase 1 trials (14)
Other trials (3)
Organizations
Organization Involved with Phase 4 Indications (3)
Organization Involved with Phase 3 Indications (5)
Organization Involved with Phase 2 Indications (17)
- Takeda
- Pfizer
- National Cancer Institute (NCI)
- University of Arizona
- Case Western Reserve University
- Helmholtz Centre for Infection Research
- Johns Hopkins University
- University of Groningen
- University of Michigan
- University of South Carolina
- Columbia University
- University of Cambridge
- Medical University of South Carolina
- Hammersmith Medicines Research
- University of Texas at Houston
- Johannes Gutenburg University
- National Institute for Health Research, United Kingdom
Organization Involved with Phase 1 Indications (12)
- Effexus Pharmaceutical
- University of Roma La Sapienza
- Baylor University
- Main Line Health
- William Marsh Rice University
- Icahn School of Medicine at Mount Sinai
- University of Gothenburg
- State University of New York, Buffalo
- Washington University in St. Louis
- Department of Veteran Affairs
- Sharpe-Strumia Research Foundation
- Cancer Research Foundation of America
Organization Involved with Other Experimental Indications (14)
- 3M
- Bayer
- Centre of Postgraduate Medical Education
- Gloucestershire Hospitals NHS Foundation Trust
- HSK Wiesbaden
- Kaohsiung Medical University
- Portsmouth Hospitals NHS Trust
- Stanford University
- University of Leicester
- University of Portsmouth
- University of Sussex
- University of Chicago
- Maria Sklodowska Curie Children's Hospital
- Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust